Answers are grounded in this paper and cite their sources.
In vitro study examines how excipients affect saquinavir association with chylomicrons, suggesting improved lymphatic delivery.
This study was performed to investigate the impact of pharmaceutical excipients commonly used for lymphatic transport on in vitro drug association with chylomicrons (CM). A CM association study was conducted using saquinavir solubilized in four different pharmaceutical excipients. We observed a linear relationship between saquinavir solubility and drug association, suggesting that the solubility of saquinavir in excipients is a key determinant for successful lymphatic delivery. Broadly, these results suggest that excipients with good solubilization properties may be advantageous for enhancing lymphatic drug delivery.
No takes yet. Share an insight, caveat, or question.
Ro et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: